Teleneonatology for Newborn Illness
Trial Summary
What is the purpose of this trial?
The purpose of this study is to evaluate the impact of real-time audio-video telemedicine consults with a neonatologist (termed teleneonatology) on the early health outcomes of at-risk neonates delivered in community hospitals.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment Teleneonatology for newborn illness?
Research suggests that teleneonatology, which involves remote consultations by neonatologists, can improve the quality of care for high-risk newborns in community hospitals. Studies indicate that it may enhance newborn resuscitation and improve stability scores, which predict the risk of mortality for transported neonates.12345
Is teleneonatology safe for newborns?
How is the treatment Teleneonatology different from other treatments for newborn illness?
Teleneonatology is unique because it uses telemedicine to provide remote care and expert consultation for newborns, especially in community hospitals, which can improve the quality of care and outcomes for high-risk newborns. This approach allows specialists to assist local care teams in real-time, which is not typically possible with traditional in-person treatments.12467
Research Team
Jennifer Fang, MD
Principal Investigator
Mayo Clinic
Bart Demaerschalk, MD
Principal Investigator
Mayo Clinic
Meegan G Van Straaten, MSPH
Principal Investigator
Mayo Clinic
Eligibility Criteria
The TELENEO Trial is for newborns needing advanced resuscitation in community hospitals and the physicians attending these births. Eligible babies may have received ventilation or chest compressions, or be born preterm (<32 weeks). Physicians with neonatal-perinatal specialty are excluded, as are babies planned for comfort care, born outside a birthing center, or with severe congenital anomalies.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Real-time audio-video telemedicine consults with a neonatologist for at-risk neonates in community hospitals
Follow-up
Participants are monitored for early mortality and morbidity outcomes
Treatment Details
Interventions
- Teleneonatology
Teleneonatology is already approved in United States, Canada, European Union for the following indications:
- Advanced neonatal resuscitations
- High-risk neonatal care
- Neonatal intensive care
- Remote neonatal consultations
- Neonatal emergency care
- Telemedicine for newborns
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator